| Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net sales | 2,214 | 2,204 | 1,999 | 2,462 | 2,909 | 3,264 | 3,006 |
|---|
| Cost of goods sold(1) | - | 1,338 | 1,249 | 1,520 | 1,812 | 1,922 | 1,797 |
|---|
| Gross profit | 876 | 866 | 749 | 942 | 1,097 | 1,342 | 1,209 |
|---|
| Selling, general and administrative | 520 | 485 | 447 | 538 | 596 | 683 | 616 |
|---|
| Research and development | 46 | 48 | 44 | 49 | 60 | 72 | 66 |
|---|
| Operating income | 311 | 333 | 38 | 355 | 440 | 587 | 527 |
|---|
| Net interest expense | - | - | - | - | - | - | -106 |
|---|
| Gain on sale of investment | - | - | - | - | - | 10 | - |
|---|
| Other expense (income) | - | - | - | 13 | 63 | -19 | 8 |
|---|
| Income before income taxes | 269 | 257 | -9 | 321 | 473 | 500 | 429 |
|---|
| Income Tax Expense (Benefit) | 38 | 35 | 38 | 48 | 73 | -68 | 188 |
|---|
| Net income from continuing operations | - | - | - | - | - | - | 241 |
|---|
| Income from discontinued operations, net of tax | - | - | - | - | - | - | 91 |
|---|
| Net income | 231 | 223 | -47 | 273 | 400 | 567 | 332 |
|---|
| Net income | 231 | 223 | -47 | 273 | 400 | 567 | 332 |
|---|
| Changes in cumulative translation adjustment | -48 | 5 | -4 | 4 | -19 | 11 | -44 |
|---|
| Changes in market value of derivative financial instruments, net of tax | - | - | - | 8 | 2 | -15 | 3 |
|---|
| Comprehensive income attributable to nVent | 180 | 232 | -44 | 285 | 383 | 563 | 291 |
|---|
| Discontinued operations (in dollars per share) | - | - | - | - | - | - | 0.55 |
|---|
| Continuing operations (in dollars per share) | - | - | - | - | - | - | 1.45 |
|---|
| Basic (dollars per share) | - | 1.3 | -0.28 | 1.63 | 2.4 | 3.42 | 2 |
|---|
| Continuing operations (in dollars per share) | - | - | - | - | - | - | 1.43 |
|---|
| Discontinued operations (in dollars per share) | - | - | - | - | - | - | 0.54 |
|---|
| Diluted (dollars per share) | 1.28 | 1.29 | -0.28 | 1.61 | 2.38 | 3.37 | 1.97 |
|---|